Article Details
Retrieved on: 2021-03-03 07:29:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The court determined that asserted claims in three of AstraZeneca's patents protecting asthma treatment Symbicort in the US are not invalid.
Article found on: www.proactiveinvestors.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here